根据ESI于2020年7月9日发布的数据，我校高被引论文（Highly Cited Papers）127篇，热点论文（Hot Papers）10篇，见附件：2020年7月yl23455永利高被引论文及热点论文简表。详情如下。
从学科角度看，在127篇高被引论文中，临床医学最多（76篇），占比59.84%，分子生物学与遗传学（14篇）第二，占比11.02%，生物学与生物化学8篇（6.30%）紧跟其后。
|
序号 |
高被引论文 Research Field |
202005 |
202007 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
1 |
CLINICAL MEDICINE |
70 |
60.87% |
76 |
59.84% |
|
2 |
MOLECULAR BIOLOGY & GENETICS |
9 |
7.83% |
14 |
11.02% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
8 |
6.96% |
8 |
6.30% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
6 |
5.22% |
6 |
4.72% |
|
5 |
NEUROSCIENCE & BEHAVIOR |
5 |
4.35% |
5 |
3.94% |
|
6 |
ENGINEERING |
3 |
2.61% |
2 |
1.57% |
|
7 |
MICROBIOLOGY |
3 |
2.61% |
5 |
3.94% |
|
8 |
AGRICULTURAL SCIENCES |
2 |
1.74% |
2 |
1.57% |
|
9 |
CHEMISTRY |
2 |
1.74% |
2 |
1.57% |
|
10 |
PHYSICS |
1 |
0.87% |
1 |
0.79% |
|
11 |
MATERIALS SCIENCE |
1 |
0.87% |
2 |
1.57% |
|
12 |
PSYCHIATRY/PSYCHOLOGY |
2 |
1.74% |
2 |
1.57% |
|
13 |
MULTIDISCIPLINARY |
1 |
0.87% |
1 |
0.79% |
|
14 |
IMMUNOLOGY |
1 |
0.87% |
0 |
0.00% |
|
15 |
ENVIRONMENT/ECOLOGY |
1 |
0.87% |
1 |
0.79% |
|
16 |
合计 |
115 |
100.00% |
127 |
100.00% |
|
序号 |
2020年7月我校10篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
MINIMAL INFORMATION FOR STUDIES OF EXTRACELLULAR VESICLES 2018 (MISEV2018): A POSITION STATEMENT OF THE INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES AND UPDATE OF THE MISEV2014 GUIDELINES |
JOURNAL OF EXTRACELLULAR VESICLES 7 (1): - NOV 23 2018 |
10.1080/20013078.2018.1535750 |
BIOLOGY & BIOCHEMISTRY |
568 |
|
2 |
ALIROCUMAB AND CARDIOVASCULAR OUTCOMES AFTER ACUTE CORONARY SYNDROME |
NEW ENGLAND JOURNAL OF MEDICINE 379 (22): 2097-2107 NOV 29 2018 |
10.1056/NEJMoa1801174 |
CLINICAL MEDICINE |
366 |
|
3 |
CLINICAL CHARACTERISTICS OF CORONAVIRUS DISEASE 2019 IN CHINA |
NEW ENGLAND JOURNAL OF MEDICINE 382 (18): 1708-1720 APR 30 2020 |
10.1056/NEJMoa2002032 |
CLINICAL MEDICINE |
196 |
|
4 |
PROTEOMICS IDENTIFIES NEW THERAPEUTIC TARGETS OF EARLY-STAGE HEPATOCELLULAR CARCINOMA |
NATURE 567 (7747): 257-+ MAR 14 2019 |
10.1038/s41586-019-0987-8 |
MULTIDISCIPLINARY |
57 |
|
5 |
ATRASENTAN AND RENAL EVENTS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE (SONAR): A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL |
LANCET 393 (10184): 1937-1947 MAY 11 2019 |
10.1016/S0140-6736(19)30772-X |
CLINICAL MEDICINE |
42 |
|
6 |
ROXADUSTAT FOR ANEMIA IN PATIENTS WITH KIDNEY DISEASE NOT RECEIVING DIALYSIS |
NEW ENGLAND JOURNAL OF MEDICINE 381 (11): 1001-1010 SEP 12 2019 |
10.1056/NEJMoa1813599 |
CLINICAL MEDICINE |
34 |
|
7 |
EFFECT OF LAPAROSCOPIC VS OPEN DISTAL GASTRECTOMY ON 3-YEAR DISEASE-FREE SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER THE CLASS-01 RANDOMIZED CLINICAL TRIAL |
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 321 (20): 1983-1992 MAY 28 2019 |
10.1001/jama.2019.5359 |
CLINICAL MEDICINE |
33 |
|
8 |
ROXADUSTAT TREATMENT FOR ANEMIA IN PATIENTS UNDERGOING LONG-TERM DIALYSIS |
NEW ENGLAND JOURNAL OF MEDICINE 381 (11): 1011-1022 SEP 12 2019 |
10.1056/NEJMoa1901713 |
CLINICAL MEDICINE |
24 |
|
9 |
INCREASING ACCESS TO INTEGRATED ESKD CARE AS PART OF UNIVERSAL HEALTH COVERAGE |
KIDNEY INTERNATIONAL 95 (4): S1-S33 SUPPL. S APR 2019 |
10.1016/j.kint.2018.12.005 |
CLINICAL MEDICINE |
17 |
|
10 |
CHARACTERISTICS OF AND PUBLIC HEALTH RESPONSES TO THE CORONAVIRUS DISEASE 2019 OUTBREAK IN CHINA |
JOURNAL OF CLINICAL MEDICINE 9 (2): - FEB 2020 |
10.3390/jcm9020575 |
CLINICAL MEDICINE |
9 |